EM

Elangbam Monorama Devi

Active Director Director DIN 09260686
DIN 09260686 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Elangbam Monorama Devi

Data last updated:

Elangbam Monorama Devi is a Director at Wymax Pharma And Research Private Limited (since 2021). The company operates in Chemicals.

DIN 09260686
Primary Designation Director
Industry Chemicals
First Appointment 29 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jul 20212021Active

Board colleagues of Elangbam Monorama Devi

Directorship timeline

Open interactive timeline →
Wymax Pharma And Research Private Limited
Premium access

Shareholding and investment profile for Elangbam Monorama Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elangbam Monorama Devi

Elangbam Monorama Devi currently holds 1 directorship: Wymax Pharma And Research Private Limited (Director, since 29 Jul 2021).

Elangbam Monorama Devi was first appointed on 29 Jul 2021 as Director at Wymax Pharma And Research Private Limited.

The current boards of Elangbam Monorama Devi's companies include Kshetrimayum Chitrarekha Devi (Wymax Pharma And Research Private Limited), Ningombam Robita Devi (Wymax Pharma And Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available